<div id="readability-page-1"><div><p><span></span></p><ul><li>MENDRA LAUNCHES WITH $82 MILLION SERIES A TO ACQUIRE, DEVELOP, AND COMMERCIALIZE THERAPEUTICS FOR HIGH UNMET NEED RARE DISEASES</li><li>MENDRA: ROUND WAS CO-LED BY ORBIMED, 8VC, AND 5AM VENTURES WITH PARTICIPATION FROM LUX CAPITAL AND WING VC</li></ul></div></div>

<p>MENDRA LAUNCHES WITH $82 MILLION SERIES A TO ACQUIRE, DEVELOP, AND COMMERCIALIZE THERAPEUTICS FOR HIGH UNMET NEED RARE DISEASESMENDRA: ROUND WAS CO-LED BY ORBIMED, 8VC, AND 5AM VENTURES WITH PARTICIPATION FROM LUX CAPITAL AND WING VC</p>

Reuters

ENDRA LIFE SCIENCES INC

iShares US Medical Devices

Globus Medical Inc 

iShares Biotechnology ETF

Invesco Biotechnology & Genome ETF

Proshares Ultra Nasdaq Biotech

Endra Life Sciences

First Trust NYSE Arca Biotech Index Fd

ALPS Medical Breakthrough

VanEck Biotech ETF

Oramed Pharma

SPDR S&P Biotech

OncoMed Pharmaceuticals, Inc.

Mendra Launches With $82M Series A To Acquire, Develop, Commercialize Therapeutics For High Unmet Need Rare Diseases